David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.33% |
| 2 | Technology | 14.87% |
| 3 | Consumer Discretionary | 9.92% |
| 4 | Healthcare | 7.34% |
| 5 | Financials | 7.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
COOL
1726
DELISTED
Corner Growth Acquisition Corp. Class A Ordinary Shares
COOL
| $6.53M | 0.01% |
669,317
+365,360
| +120% | +$3.55M |
|
1727
Rocket Companies
RKT
$40.4B
| $6.53M | 0.01% |
407,146
+246,416
| +153% | +$4.31M |
|
|
XONE
1728
DELISTED
The ExOne Company
XONE
| $6.53M | 0.01% |
279,319
-68,929
| -20% | -$1.45M |
|
1729
Cooper Companies
COO
$14B
| $6.52M | 0.01% |
63,108
-13,712
| -18% | -$1.46M |
|
|
ABB
1730
DELISTED
ABB Ltd
ABB
| $6.51M | 0.01% |
195,209
-32,827
| -14% | -$1.19M |
|
1731
Agios Pharmaceuticals
AGIO
$2.05B
| $6.5M | 0.01% |
140,754
+119,366
| +558% | +$5.77M |
|
1732
CALL
AstraZeneca
AZN
$256B
| $6.47M | 0.01% |
53,900
+16,700
| +45% | +$1.94M |
|
1733
GDS Holdings
GDS
$6.74B
| $6.47M | 0.01% |
114,262
-91,318
| -44% | -$5.63M |
|
|
WARR
1734
DELISTED
Warrior Technologies Acquisition Company
WARR
| $6.46M | 0.01% |
658,946
+642,280
| +3,854% | +$6.25M |
|
1735
Syndax Pharmaceuticals
SNDX
$1.79B
| $6.44M | 0.01% |
337,146
-73,321
| -18% | -$1.22M |
|
1736
American Electric Power
AEP
$66.6B
| $6.44M | 0.01% |
79,354
-182,857
| -70% | -$16M |
|
1737
Sixth Street Specialty
TSLX
$1.8B
| $6.44M | 0.01% |
289,989
-62,751
| -18% | -$1.44M |
|
1738
PUT
Appian
APPN
$2.92B
| $6.42M | 0.01% |
69,400
-16,300
| -19% | -$1.81M |
|
1739
CALL
Chewy
CHWY
$9.42B
| $6.42M | 0.01% |
94,200
-92,700
| -50% | -$7.67M |
|
1740
Lufax Holding
LU
$1.13B
| $6.4M | 0.01% |
229,296
+212,471
| +1,263% | +$7.05M |
|
1741
Huazhu Hotels Group
HTHT
$14.9B
| $6.4M | 0.01% |
139,542
-40,036
| -22% | -$1.89M |
|
1742
Fossil Group
FOSL
$325M
| $6.4M | 0.01% |
539,896
-25,559
| -5% | -$331K |
|
|
SHQA
1743
DELISTED
Shelter Acquisition Corporation I Class A Common Stock
SHQA
| $6.39M | 0.01% |
+657,421
| New | +$6.39M |
|
1744
First Financial Bankshares
FFIN
$4.76B
| $6.37M | 0.01% |
138,726
+116,870
| +535% | +$5.54M |
|
|
SWTX
1745
DELISTED
SpringWorks Therapeutics
SWTX
| $6.37M | 0.01% |
100,457
-25,422
| -20% | -$1.96M |
|
1746
Murphy USA
MUSA
$9.48B
| $6.36M | 0.01% |
38,017
-36,844
| -49% | -$5.56M |
|
1747
PUT
Trip.com Group
TCOM
$28.2B
| $6.34M | 0.01% |
206,300
+150,600
| +270% | +$4.33M |
|
1748
PUT
Dow Inc
DOW
$21.9B
| $6.33M | 0.01% |
110,000
| – | – |
|
|
CTEV
1749
Claritev Corp
CTEV
$674M
| $6.31M | 0.01% |
28,032
-9,178
| -25% | -$2.48M |
|
1750
Strategic Education
STRA
$1.92B
| $6.3M | 0.01% |
89,438
-67,972
| -43% | -$5.07M |
|
Similar funds
David Shaw's Q3 2021 Portfolio in Review
As of Q3 2021, David Shaw held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
David Shaw withdrew a net $13.7B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, up from 35% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Sea Limited worth $206M.
- David Shaw's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- David Shaw added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- David Shaw's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- David Shaw fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- David Shaw's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- David Shaw opened 915 new positions and closed 695 in Q3 2021.
- David Shaw's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.